Top Stocks to Watch on December 5: L&T, Torrent Pharma, Indus Towers, Bharat Forge, IGL, and More

Published on:

stocks to watch

As the Indian stock market gears up for trading on December 5, 2024, several key stocks are expected to draw significant attention from investors. With various corporate developments and market movements, here’s a closer look at the top stocks to watch today.

Key Stocks in Focus

1. Indus Towers

Indus Towers is set to be in the spotlight as Vodafone plans to sell a 3% stake in the company to clear outstanding debt. This transaction is valued at approximately ₹2,841 crore, which may influence the stock’s performance in the coming days.

For Experts Recommendation Join Now
  • Stake Sale: Vodafone to sell 3% stake
  • Transaction Value: ₹2,841 crore

2. Bharat Forge

Bharat Forge has approved the launch of its Qualified Institutions Placement (QIP), setting a floor price of ₹1,323.54 per share. This move is aimed at raising capital and follows prior approvals from the Board of Directors.

  • QIP Launch: Floor price set at ₹1,323.54
  • Purpose: Capital raising for growth initiatives

3. PG Electroplast

PG Electroplast has also initiated its QIP, with a floor price established at ₹705.18 per share. This decision was made following necessary approvals from the Board and shareholders.

  • QIP Launch: Floor price at ₹705.18
  • Approval Status: Board and shareholder approvals obtained

4. IGL (Indraprastha Gas Limited)

IGL is preparing for a significant meeting on December 10 to discuss a proposed bonus issue of shares. This would mark the first time IGL has declared a bonus share issue, setting it apart from its competitors in the City Gas sector.

  • Bonus Issue Discussion Date: December 10
  • Significance: First bonus issue for IGL

5. L&T (Larsen & Toubro)

L&T has successfully completed the acquisition of a 15% stake in E2E Networks Ltd through preferential allotment and plans to acquire an additional 6% stake from promoters by May 30, 2025.

  • Acquisition Details: 15% stake completed; additional 6% planned
  • Strategic Move: Strengthening position in tech infrastructure

6. Torrent Pharma

Torrent Pharma has entered into an agreement to acquire several brands from Boehringer Ingelheim International GmbH. This acquisition includes drugs that are expected to enhance Torrent’s portfolio significantly.

  • Acquisition Details: Brands Cospiaq and Xilingio
  • Completion Timeline: Expected by March 2025

7. Suraj Estate

Suraj Estate has expanded its portfolio by acquiring land in Mumbai for ₹101 crore through its subsidiary. This strategic acquisition aims to enhance its real estate offerings.

  • Land Acquisition Cost: ₹101 crore
  • Location: Senapati Bapat Marg, Mahim (W), Mumbai

8. Mazagon Dock Shipbuilders

Mazagon Dock has confirmed ongoing commercial negotiations regarding the potential acquisition of three additional Scorpene-class submarines under Project 75, although no final communication has been received yet.

  • Project Status: Ongoing negotiations for submarines
  • Significance: Enhances defense capabilities

9. Gallantt Ispat

Gallantt Ispat announced receipt of ₹80.45 crore in partial reimbursement under state industrial promotion policies, which will support its manufacturing operations.

  • Reimbursement Amount: ₹80.45 crore
  • Purpose: Support for SGST payments

10. Muthoot Microfin

Muthoot Microfin has implemented a reduction in interest rates for its loans, lowering rates by up to 125 basis points for certain products. This move aims to make borrowing more affordable for customers.

  • Interest Rate Reduction: Up to 125 bps
  • New Rates: Income-generating loans at 23.05%

Conclusion

Investors should keep a close eye on these stocks as they navigate through various corporate developments and market trends on December 5, 2024. Each of these companies presents unique opportunities that could influence their stock performance significantly. Disclaimer: This article is for informational purposes only and does not constitute financial advice or recommendations regarding stock purchases. Readers should conduct their own research or consult with financial advisors before making investment decisions related to any stocks mentioned herein. If you need any further adjustments or specific details added, please let me know!

Share This ➥
X